Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103 USD | -1.77% |
|
-3.65% | -5.77% |
06-27 | Barclays Trims Price Target on Revvity to $115 From $116 | MT |
06-20 | Bionano Genomics Says Revvity to Commercialize VIA Software | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.77% | 12.94B | |
+2.06% | 211B | |
+5.69% | 185B | |
+29.31% | 158B | |
+2.36% | 64.32B | |
+18.36% | 55.66B | |
-1.92% | 48.41B | |
-8.37% | 37.82B | |
-1.37% | 35.57B | |
+8.67% | 28.12B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 10